Steve’s research interests focus on mechanisms of platelet activation by tyrosine kinase-linked receptors (notably CLEC-2, FcgammaRIIA, GPVI and PEAR1) and in developing novel antiplatelet agents that target these receptors in thrombi-inflammatory disease. Steve is currently Editor-in-Chief of the journal Platelets and Trustee of The British Pharmacological Society and Platelet Society. Steve is a Fellow of the Academy of Medical Sciences (2002) and was the 2006 winner of the Nature/Nesta mid-career award for creative mentoring.